Unravelling gender-specific factors that link obesity to albuminuria.

European Journal of Clinical Investigation
Manuel F LandechoMarta Cuervo

Abstract

Obesity is a major public health problem, which continues to be diagnosed and classified by BMI, excluding the most elemental concepts of the precision medicine approach. Obesity does not equally affect males and females, even with the same BMI. Microalbuminuria is a risk marker of cardiovascular disease closely related to obesity. The aim of this study was to evaluate the gender-dependent differences in the development of early obesity-related disease, focusing on pathologic microalbuminuria (PMA). We developed a single-centre cross-sectional study including 1068 consecutive adults from May 2016 to January 2018, divided into two groups: one including the first 787 patients attended, evaluated as a description population; the second group included 281 subjects analysed as an external validation population. Collected data included medical history, anthropometric measures, abdominal bioimpedance and routine laboratory tests. First, we confirmed the lack of accuracy of classic obesity measures in predicting microalbuminuria. Second, we tested the utility of a tailored evaluation to predict PMA, with an area under the ROC curve of 0.78 for females and 0.82 for males. We also confirmed the different physiology of visceral adiposity ...Continue Reading

References

Jul 1, 1984·The American Journal of Clinical Nutrition·A M Roza, H M Shizgal
Feb 24, 2001·Annals of Internal Medicine·V J StevensUNKNOWN Trials for the Hypertension Prevention Research Group
Oct 3, 2002·Circulation·Hans L HillegeUNKNOWN Prevention of Renal and Vascular End Stage Disease (PREVEND) Study Group
Jul 16, 2003·Annals of Internal Medicine·Andrew S LeveyUNKNOWN National Kidney Foundation
Sep 16, 2004·American Journal of Physiology. Endocrinology and Metabolism·S Rodriguez-CuencaP Roca
Dec 1, 1918·Proceedings of the National Academy of Sciences of the United States of America·J A Harris, F G Benedict
Nov 6, 2007·The British Journal of Nutrition·Michael L Power, Jay Schulkin
Nov 14, 2008·The New England Journal of Medicine·T PischonE Riboli
Apr 13, 2011·Revista española de cardiología·Manuel F LandechoOscar Beloqui
Aug 24, 2013·Science·Rexford S Ahima, Mitchell A Lazar
May 1, 2015·JAMA : the Journal of the American Medical Association·Euan A Ashley
Sep 4, 2015·American Journal of Physiology. Endocrinology and Metabolism·Amaia RodriguezGema Frühbeck
Feb 3, 2016·Journal of Diabetes and Its Complications·Meng RenLi Yan
Sep 19, 2017·The Lancet. Diabetes & Endocrinology·Gema FrühbeckVictoria Catalán
Nov 5, 2017·European Journal of Internal Medicine·Alessandra VecchiéFabrizio Montecucco
Jan 18, 2018·JAMA : the Journal of the American Medical Association·Susan Z Yanovski, Jack A Yanovski
Jul 12, 2018·European Journal of Clinical Investigation·Xabier UnamunoVictoria Catalán
Nov 7, 2019·Nutrients·Manuel F LandechoGema Frühbeck

❮ Previous
Next ❯

Citations

Jan 6, 2021·Environment International·Changhong WeiXiangang Hu
Feb 2, 2022·European Journal of Clinical Investigation·Anand UpadhyayaThomas Hellmuth Schindler

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.